Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Express Scripts
Deloitte
Johnson and Johnson
Julphar
Dow
Citi
AstraZeneca
Cerilliant

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021689

« Back to Dashboard

NDA 021689 describes NEXIUM IV, which is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from two suppliers. Additional details are available on the NEXIUM IV profile page.

The generic ingredient in NEXIUM IV is esomeprazole sodium. There are seventy drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the esomeprazole sodium profile page.
Summary for 021689
Tradename:NEXIUM IV
Applicant:Astrazeneca Pharms
Ingredient:esomeprazole sodium
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021689
Suppliers and Packaging for NDA: 021689
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEXIUM IV esomeprazole sodium INJECTABLE;INTRAVENOUS 021689 NDA AstraZeneca Pharmaceuticals LP 0186-6020 N 0186-6020-01
NEXIUM IV esomeprazole sodium INJECTABLE;INTRAVENOUS 021689 NDA AstraZeneca Pharmaceuticals LP 0186-6040 N 0186-6040-01

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INTRAVENOUSStrengthEQ 20MG BASE/VIAL
Approval Date:Mar 31, 2005TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVENOUSStrengthEQ 40MG BASE/VIAL
Approval Date:Mar 31, 2005TE:APRLD:Yes

Expired US Patents for NDA 021689

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms NEXIUM IV esomeprazole sodium INJECTABLE;INTRAVENOUS 021689-002 Mar 31, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca Pharms NEXIUM IV esomeprazole sodium INJECTABLE;INTRAVENOUS 021689-001 Mar 31, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca Pharms NEXIUM IV esomeprazole sodium INJECTABLE;INTRAVENOUS 021689-002 Mar 31, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca Pharms NEXIUM IV esomeprazole sodium INJECTABLE;INTRAVENOUS 021689-001 Mar 31, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
AstraZeneca
Dow
Argus Health
Medtronic
Express Scripts
Federal Trade Commission
Boehringer Ingelheim
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.